{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T18:51:19Z","timestamp":1791917479435,"version":"4.3.4"},"reference-count":165,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"Natural Science Foundation of China","doi-asserted-by":"crossref","award":["Grant No. 82070643"],"award-info":[{"award-number":["Grant No. 82070643"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Scientific Research and Innovation Team of The First Affiliated Hospital of Zhengzhou University","award":["No. ZYCXTD2023002 and QNCXTD2023002"],"award-info":[{"award-number":["No. ZYCXTD2023002 and QNCXTD2023002"]}]},{"name":"The Academician Workstation, Center of Spatiotemporal Omics, the FirstAffiliated Hospital of Zhengzhou University.","award":["The Academician Workstation, Center of Spatiotemporal Omics, the FirstAffiliated Hospital of Zhengzhou University."],"award-info":[{"award-number":["The Academician Workstation, Center of Spatiotemporal Omics, the FirstAffiliated Hospital of Zhengzhou University."]}]},{"name":"The Funding for The Outstanding Young Scientist Program of the Henan Natural Science Foundation","award":["252300421020"],"award-info":[{"award-number":["252300421020"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-025-07037-6","type":"journal-article","created":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T10:21:16Z","timestamp":1759314076000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Mechanistic insights into post-translational modifications in hepatic fibrosis: pathogenic roles and therapeutic potentials"],"prefix":"10.1186","volume":"23","author":[{"given":"Xiwen","family":"Bai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhihan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianbin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ranran","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0954-5472","authenticated-orcid":false,"given":"Zujiang","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,1]]},"reference":[{"issue":"1","key":"7037_CR1","first-page":"1","volume":"33","author":"M Li","year":"2020","unstructured":"Li M, et al. Burden of cirrhosis and other chronic liver diseases caused by specific etiologies in China, 1990\u20132016: findings from the Global Burden of Disease Study 2016. Biomed Environ Sci. 2020;33(1):1\u201310.","journal-title":"Biomed Environ Sci"},{"key":"7037_CR2","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1186\/s12916-014-0145-y","volume":"12","author":"AA Mokdad","year":"2014","unstructured":"Mokdad AA, et al. Liver cirrhosis mortality in 187 countries between 1980 and 2010: a systematic analysis. BMC Med. 2014;12:145.","journal-title":"BMC Med"},{"issue":"3","key":"7037_CR3","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/s12072-018-9865-y","volume":"12","author":"MCS Wong","year":"2018","unstructured":"Wong MCS, Huang J. The growing burden of liver cirrhosis: implications for preventive measures. Hepatol Int. 2018;12(3):201\u20133.","journal-title":"Hepatol Int"},{"issue":"9959","key":"7037_CR4","doi-asserted-by":"publisher","first-page":"2053","DOI":"10.1016\/S0140-6736(14)60220-8","volume":"384","author":"C Tr\u00e9po","year":"2014","unstructured":"Tr\u00e9po C, Chan HL, Lok A. Hepatitis B virus infection. Lancet. 2014;384(9959):2053\u201363.","journal-title":"Lancet"},{"key":"7037_CR5","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.mehy.2017.08.005","volume":"108","author":"Y Zhou","year":"2017","unstructured":"Zhou Y, et al. How hepatitis B virus causes cirrhosis and liver cancer. Med Hypotheses. 2017;108:52\u20133.","journal-title":"Med Hypotheses"},{"issue":"2","key":"7037_CR6","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1172\/JCI24282","volume":"115","author":"R Bataller","year":"2005","unstructured":"Bataller R, Brenner DA. Liver fibrosis. J Clin Invest. 2005;115(2):209\u201318.","journal-title":"J Clin Invest"},{"issue":"4","key":"7037_CR7","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1002\/j.2040-4603.2013.tb00529.x","volume":"3","author":"JE Puche","year":"2013","unstructured":"Puche JE, Saiman Y, Friedman SL. Hepatic stellate cells and liver fibrosis. Compr Physiol. 2013;3(4):1473\u201392.","journal-title":"Compr Physiol"},{"issue":"9","key":"7037_CR8","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1089\/dna.2009.0884","volume":"28","author":"P Sysa","year":"2009","unstructured":"Sysa P, et al. Transforming growth factor-beta1 up-regulation of human alpha(1)(I) collagen is mediated by Sp1 and Smad2 transacting factors. DNA Cell Biol. 2009;28(9):425\u201334.","journal-title":"DNA Cell Biol"},{"issue":"9","key":"7037_CR9","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1111\/j.1478-3231.2006.01353.x","volume":"26","author":"H Qiang","year":"2006","unstructured":"Qiang H, et al. Differential expression genes analyzed by cDNA array in the regulation of rat hepatic fibrogenesis. Liver Int. 2006;26(9):1126\u201337.","journal-title":"Liver Int"},{"issue":"1","key":"7037_CR10","doi-asserted-by":"publisher","first-page":"81","DOI":"10.18632\/oncotarget.6447","volume":"7","author":"F Yu","year":"2016","unstructured":"Yu F, et al. Microrna-17-5p-activated Wnt\/\u03b2-catenin pathway contributes to the progression of liver fibrosis. Oncotarget. 2016;7(1):81\u201393.","journal-title":"Oncotarget"},{"issue":"6958","key":"7037_CR11","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1038\/nature02006","volume":"425","author":"R Derynck","year":"2003","unstructured":"Derynck R, Zhang YE. Smad-dependent and Smad-independent pathways in TGF-beta family signalling. Nature. 2003;425(6958):577\u201384.","journal-title":"Nature"},{"key":"7037_CR12","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1159\/000324949","volume":"170","author":"HY Lan","year":"2011","unstructured":"Lan HY, Chung ACK. Transforming growth factor-\u03b2 and Smads. Contrib Nephrol. 2011;170:75\u201382.","journal-title":"Contrib Nephrol"},{"issue":"4","key":"7037_CR13","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1002\/hep.1840110412","volume":"11","author":"M Matsuoka","year":"1990","unstructured":"Matsuoka M, Tsukamoto H. Stimulation of hepatic lipocyte collagen production by Kupffer cell-derived transforming growth factor beta: implication for a pathogenetic role in alcoholic liver fibrogenesis. Hepatology. 1990;11(4):599\u2013605.","journal-title":"Hepatology"},{"issue":"3","key":"7037_CR14","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1055\/s-2001-17550","volume":"21","author":"A Geerts","year":"2001","unstructured":"Geerts A. History, heterogeneity, developmental biology, and functions of quiescent hepatic stellate cells. Semin Liver Dis. 2001;21(3):311\u201335.","journal-title":"Semin Liver Dis"},{"issue":"24","key":"7037_CR15","doi-asserted-by":"publisher","first-page":"8681","DOI":"10.1073\/pnas.82.24.8681","volume":"82","author":"SL Friedman","year":"1985","unstructured":"Friedman SL, et al. Hepatic lipocytes: the principal collagen-producing cells of normal rat liver. Proc Natl Acad Sci U S A. 1985;82(24):8681\u20135.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"7037_CR16","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1002\/aja.1001320404","volume":"132","author":"K Wake","year":"1971","unstructured":"Wake K. \u201cSternzellen\u201d in the liver: perisinusoidal cells with special reference to storage of vitamin A. Am J Anat. 1971;132(4):429\u201362.","journal-title":"Am J Anat"},{"issue":"118","key":"7037_CR17","first-page":"1960","volume":"59","author":"WR Bi","year":"2012","unstructured":"Bi WR, Yang CQ, Shi Q. Transforming growth factor-\u03b21 induced epithelial-mesenchymal transition in hepatic fibrosis. Hepatogastroenterology. 2012;59(118):1960\u20133.","journal-title":"Hepatogastroenterology"},{"issue":"6","key":"7037_CR18","doi-asserted-by":"publisher","first-page":"1780","DOI":"10.1172\/JCI114362","volume":"84","author":"SL Friedman","year":"1989","unstructured":"Friedman SL, Arthur MJ. Activation of cultured rat hepatic lipocytes by Kupffer cell conditioned medium. Direct enhancement of matrix synthesis and stimulation of cell proliferation via induction of platelet-derived growth factor receptors. J Clin Invest. 1989;84(6):1780\u20135.","journal-title":"J Clin Invest"},{"issue":"1","key":"7037_CR19","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s13550-015-0151-x","volume":"5","author":"D Li","year":"2015","unstructured":"Li D, et al. Targeting activated hepatic stellate cells (aHSCs) for liver fibrosis imaging. EJNMMI Res. 2015;5(1):71.","journal-title":"EJNMMI Res"},{"issue":"5","key":"7037_CR20","first-page":"489","volume":"30","author":"B Cl\u00e9ment","year":"1984","unstructured":"Cl\u00e9ment B, et al. Cellular origin of collagen and fibronectin in the liver. Cell Mol Biol. 1984;30(5):489\u201396.","journal-title":"Cell Mol Biol"},{"issue":"1","key":"7037_CR21","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1038\/s41392-023-01439-y","volume":"8","author":"X Wu","year":"2023","unstructured":"Wu X, et al. Targeting protein modifications in metabolic diseases: molecular mechanisms and targeted therapies. Signal Transduct Target Ther. 2023;8(1):220.","journal-title":"Signal Transduct Target Ther"},{"key":"7037_CR22","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1038\/184056b0","volume":"184","author":"RP Ambler","year":"1959","unstructured":"Ambler RP, Rees MW. Epsilon-N-methyl-lysine in bacterial flagellar protein. Nature. 1959;184:56\u20137.","journal-title":"Nature"},{"issue":"2","key":"7037_CR23","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1210\/er.2004-0008","volume":"26","author":"DY Lee","year":"2005","unstructured":"Lee DY, et al. Role of protein methylation in regulation of transcription. Endocr Rev. 2005;26(2):147\u201370.","journal-title":"Endocr Rev"},{"issue":"8","key":"7037_CR24","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1038\/nrm.2017.35","volume":"18","author":"J Murn","year":"2017","unstructured":"Murn J, Shi Y. The winding path of protein methylation research: milestones and new frontiers. Nat Rev Mol Cell Biol. 2017;18(8):517\u201327.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"5","key":"7037_CR25","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.tibs.2013.02.004","volume":"38","author":"SG Clarke","year":"2013","unstructured":"Clarke SG. Protein methylation at the surface and buried deep: thinking outside the histone box. Trends Biochem Sci. 2013;38(5):243\u201352.","journal-title":"Trends Biochem Sci"},{"issue":"1","key":"7037_CR26","doi-asserted-by":"publisher","first-page":"163","DOI":"10.2217\/epi.09.3","volume":"1","author":"T Petrossian","year":"2009","unstructured":"Petrossian T, Clarke S. Bioinformatic identification of novel methyltransferases. Epigenomics. 2009;1(1):163\u201375.","journal-title":"Epigenomics"},{"issue":"8","key":"7037_CR27","doi-asserted-by":"publisher","first-page":"e23168","DOI":"10.1371\/journal.pone.0023168","volume":"6","author":"T Wlodarski","year":"2011","unstructured":"Wlodarski T, et al. Comprehensive structural and substrate specificity classification of the Saccharomyces cerevisiae methyltransferome. PLoS ONE. 2011;6(8):e23168.","journal-title":"PLoS ONE"},{"issue":"5","key":"7037_CR28","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1038\/nrg3173","volume":"13","author":"EL Greer","year":"2012","unstructured":"Greer EL, Shi Y. Histone methylation: a dynamic mark in health, disease and inheritance. Nat Rev Genet. 2012;13(5):343\u201357.","journal-title":"Nat Rev Genet"},{"key":"7037_CR29","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1021\/bi00889a003","volume":"3","author":"K Murray","year":"1964","unstructured":"Murray K. The occurrence of epsilon-N-methyl lysine in histones. Biochemistry. 1964;3:10\u20135.","journal-title":"Biochemistry"},{"issue":"1","key":"7037_CR30","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1038\/nrc3409","volume":"13","author":"Y Yang","year":"2013","unstructured":"Yang Y, Bedford MT. Protein arginine methyltransferases and cancer. Nat Rev Cancer. 2013;13(1):37\u201350.","journal-title":"Nat Rev Cancer"},{"issue":"4","key":"7037_CR31","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.molcel.2012.11.006","volume":"48","author":"JC Black","year":"2012","unstructured":"Black JC, Van Rechem C, Whetstine JR. Histone lysine methylation dynamics: establishment, regulation, and biological impact. Mol Cell. 2012;48(4):491\u2013507.","journal-title":"Mol Cell"},{"issue":"1","key":"7037_CR32","doi-asserted-by":"publisher","first-page":"M110.000976","DOI":"10.1074\/mcp.M110.000976","volume":"10","author":"TC Petrossian","year":"2011","unstructured":"Petrossian TC, Clarke SG. Uncovering the human methyltransferasome. Mol Cell Proteomics. 2011;10(1):M110.000976.","journal-title":"Mol Cell Proteomics"},{"issue":"7","key":"7037_CR33","doi-asserted-by":"publisher","first-page":"699","DOI":"10.2174\/1389203721666200507091952","volume":"21","author":"AA Al-Hamashi","year":"2020","unstructured":"Al-Hamashi AA, Diaz K, Huang R. Non-histone arginine methylation by protein arginine methyltransferases. Curr Protein Pept Sci. 2020;21(7):699\u2013712.","journal-title":"Curr Protein Pept Sci"},{"issue":"1","key":"7037_CR34","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1038\/nrm3915","volume":"16","author":"KK Biggar","year":"2015","unstructured":"Biggar KK, Li SSC. Non-histone protein methylation as a regulator of cellular signalling and function. Nat Rev Mol Cell Biol. 2015;16(1):5\u201317.","journal-title":"Nat Rev Mol Cell Biol."},{"issue":"10","key":"7037_CR35","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1038\/nrm2502","volume":"9","author":"RJ Sims","year":"2008","unstructured":"Sims RJ, Reinberg D. Is there a code embedded in proteins that is based on post-translational modifications? Nat Rev Mol Cell Biol. 2008;9(10):815\u201320.","journal-title":"Nat Rev Mol Cell Biol."},{"issue":"6","key":"7037_CR36","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1038\/nchembio.88","volume":"4","author":"P Rathert","year":"2008","unstructured":"Rathert P, et al. Protein lysine methyltransferase G9a acts on non-histone targets. Nat Chem Biol. 2008;4(6):344\u20136.","journal-title":"Nat Chem Biol"},{"issue":"8","key":"7037_CR37","doi-asserted-by":"publisher","first-page":"3239","DOI":"10.1021\/acs.jmedchem.6b01817","volume":"61","author":"ZY Buuh","year":"2017","unstructured":"Buuh ZY, Lyu Z, Wang RE. Interrogating the roles of post-translational modifications of non-histone proteins: miniperspective. J Med Chem. 2017;61(8):3239\u201352.","journal-title":"J Med Chem."},{"issue":"5","key":"7037_CR38","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1073\/pnas.51.5.786","volume":"51","author":"VG Allfrey","year":"1964","unstructured":"Allfrey VG, Faulkner R, Mirsky AE. Acetylation and methylation of histones and their possible role in the regulation of RNA synthesis. Proc Natl Acad Sci U S A. 1964;51(5):786\u201394.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"7037_CR39","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1038\/nrm3931","volume":"16","author":"E Verdin","year":"2015","unstructured":"Verdin E, Ott M. 50 years of protein acetylation: from gene regulation to epigenetics, metabolism and beyond. Nat Rev Mol Cell Biol. 2015;16(4):258\u201364.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"15","key":"7037_CR40","doi-asserted-by":"publisher","first-page":"2759","DOI":"10.1002\/jcc.21569","volume":"31","author":"TY Lee","year":"2010","unstructured":"Lee TY, et al. N-ace: using solvent accessibility and physicochemical properties to identify protein N-acetylation sites. J Comput Chem. 2010;31(15):2759\u201371.","journal-title":"J Comput Chem"},{"issue":"5","key":"7037_CR41","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1038\/s41580-021-00441-y","volume":"23","author":"M Shvedunova","year":"2022","unstructured":"Shvedunova M, Akhtar A. Modulation of cellular processes by histone and non-histone protein acetylation. Nat Rev Mol Cell Biol. 2022;23(5):329\u201349.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"4","key":"7037_CR42","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1515\/hsz-2011-0228","volume":"393","author":"J Hollebeke","year":"2012","unstructured":"Hollebeke J, Van Damme P, Gevaert K. N-terminal acetylation and other functions of N\u03b1-acetyltransferases. Biol Chem. 2012;393(4):291\u20138.","journal-title":"Biol Chem"},{"issue":"2","key":"7037_CR43","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1042\/bj0870258","volume":"87","author":"DM Phillips","year":"1963","unstructured":"Phillips DM. The presence of acetyl groups of histones. Biochem J. 1963;87(2):258\u201363.","journal-title":"Biochem J"},{"issue":"9","key":"7037_CR44","doi-asserted-by":"publisher","first-page":"4868","DOI":"10.1073\/pnas.96.9.4868","volume":"96","author":"CM Grozinger","year":"1999","unstructured":"Grozinger CM, Hassig CA, Schreiber SL. Three proteins define a class of human histone deacetylases related to yeast Hda1p. Proc Natl Acad Sci U S A. 1999;96(9):4868\u201373.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"7037_CR45","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1042\/bj2650023","volume":"265","author":"A Csordas","year":"1990","unstructured":"Csordas A. On the biological role of histone acetylation. Biochem J. 1990;265(1):23\u201338.","journal-title":"Biochem J"},{"issue":"Pt 1","key":"7037_CR46","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1242\/jcs.99.1.13","volume":"99","author":"BM Turner","year":"1991","unstructured":"Turner BM. Histone acetylation and control of gene expression. J Cell Sci. 1991;99(Pt 1):13\u201320.","journal-title":"J Cell Sci"},{"issue":"6649","key":"7037_CR47","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1038\/38664","volume":"389","author":"M Grunstein","year":"1997","unstructured":"Grunstein M. Histone acetylation in chromatin structure and transcription. Nature. 1997;389(6649):349\u201352.","journal-title":"Nature"},{"issue":"6765","key":"7037_CR48","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/47412","volume":"403","author":"BD Strahl","year":"2000","unstructured":"Strahl BD, Allis CD. The language of covalent histone modifications. Nature. 2000;403(6765):41\u20135.","journal-title":"Nature"},{"issue":"1","key":"7037_CR49","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/S0021-9258(17)46054-6","volume":"2","author":"PA Levene","year":"1906","unstructured":"Levene PA, Alsberg CL. The cleavage products of vitellin. J Biol Chem. 1906;2(1):127\u201333.","journal-title":"J Biol Chem"},{"issue":"1","key":"7037_CR50","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/S0021-9258(19)52288-8","volume":"216","author":"EG Krebs","year":"1955","unstructured":"Krebs EG, Fischer EH. Phosphorylase activity of skeletal muscle extracts. J Biol Chem. 1955;216(1):113\u201320.","journal-title":"J Biol Chem"},{"issue":"1","key":"7037_CR51","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/S0021-9258(19)52289-X","volume":"216","author":"EH Fischer","year":"1955","unstructured":"Fischer EH, Krebs EG. Conversion of phosphorylase b to phosphorylase a in muscle extracts. J Biol Chem. 1955;216(1):121\u201332.","journal-title":"J Biol Chem"},{"issue":"2","key":"7037_CR52","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/S0955-0674(97)80063-4","volume":"9","author":"BG Neel","year":"1997","unstructured":"Neel BG, Tonks NK. Protein tyrosine phosphatases in signal transduction. Curr Opin Cell Biol. 1997;9(2):193\u2013204.","journal-title":"Curr Opin Cell Biol"},{"issue":"5600","key":"7037_CR53","doi-asserted-by":"publisher","first-page":"1912","DOI":"10.1126\/science.1075762","volume":"298","author":"G Manning","year":"2002","unstructured":"Manning G, et al. The protein kinase complement of the human genome. Science. 2002;298(5600):1912\u201334.","journal-title":"Science"},{"issue":"12","key":"7037_CR54","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/0968-0004(89)90184-9","volume":"14","author":"NK Tonks","year":"1989","unstructured":"Tonks NK, Charbonneau H. Protein tyrosine dephosphorylation and signal transduction. Trends Biochem Sci. 1989;14(12):497\u2013500.","journal-title":"Trends Biochem Sci"},{"issue":"1","key":"7037_CR55","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bbamcr.2018.10.019","volume":"1866","author":"P Ruvolo","year":"2019","unstructured":"Ruvolo P, Janssens V. Protein phosphatases as critical regulators for cellular homeostasis. Biochim Biophys Acta-Mol Cell Res. 2019;1866(1):1\u20131.","journal-title":"Biochim Biophys Acta-Mol Cell Res."},{"issue":"6","key":"7037_CR56","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1016\/0959-440X(95)80004-2","volume":"5","author":"D Barford","year":"1995","unstructured":"Barford D. Protein phosphatases. Curr Opin Struct Biol. 1995;5(6):728\u201334.","journal-title":"Curr Opin Struct Biol"},{"issue":"7779","key":"7037_CR57","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1038\/s41586-019-1678-1","volume":"574","author":"D Zhang","year":"2019","unstructured":"Zhang D, et al. Metabolic regulation of gene expression by histone lactylation. Nature. 2019;574(7779):575\u201380.","journal-title":"Nature"},{"issue":"2","key":"7037_CR58","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.tig.2021.09.009","volume":"38","author":"X Dai","year":"2022","unstructured":"Dai X, et al. Histone lactylation: epigenetic mark of glycolytic switch. Trends Genet. 2022;38(2):124\u20137.","journal-title":"Trends Genet"},{"issue":"3","key":"7037_CR59","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.tibs.2019.12.004","volume":"45","author":"MV Liberti","year":"2020","unstructured":"Liberti MV, Locasale JW. Histone lactylation: a new role for glucose metabolism. Trends Biochem Sci. 2020;45(3):179\u201382.","journal-title":"Trends Biochem Sci"},{"key":"7037_CR60","doi-asserted-by":"publisher","first-page":"688910","DOI":"10.3389\/fimmu.2021.688910","volume":"12","author":"AN Chen","year":"2021","unstructured":"Chen AN, et al. Lactylation, a novel metabolic reprogramming code: current status and prospects. Front Immunol. 2021;12:688910.","journal-title":"Front Immunol"},{"issue":"7779","key":"7037_CR61","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1038\/d41586-019-03122-1","volume":"574","author":"LT Izzo","year":"2019","unstructured":"Izzo LT, Wellen KE. Histone lactylation links metabolism and gene regulation. Nature. 2019;574(7779):492\u20133.","journal-title":"Nature"},{"key":"7037_CR62","doi-asserted-by":"publisher","first-page":"719720","DOI":"10.3389\/fcell.2021.719720","volume":"9","author":"N Zhang","year":"2021","unstructured":"Zhang N, et al. Protein lactylation critically regulates energy metabolism in the protozoan parasite Trypanosoma brucei. Front Cell Dev Biol. 2021;9:719720.","journal-title":"Front Cell Dev Biol"},{"issue":"3","key":"7037_CR63","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/BF00224611","volume":"40","author":"H Busch","year":"1981","unstructured":"Busch H, Goldknopf IL. Ubiquitin\u2014protein conjugates. Mol Cell Biochem. 1981;40(3):173\u201387.","journal-title":"Mol Cell Biochem"},{"issue":"5","key":"7037_CR64","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1038\/s41580-021-00448-5","volume":"23","author":"DA Cruz Walma","year":"2022","unstructured":"Cruz Walma DA, Chen Z, Bullock AN, Yamada KM. Ubiquitin ligases: guardians of mammalian development. Nat Rev Mol Cell Biol. 2022;23(5):350\u201367.","journal-title":"Nat Rev Mol Cell Biol."},{"key":"7037_CR65","doi-asserted-by":"publisher","DOI":"10.1199\/tab.0174","volume":"12","author":"J Callis","year":"2014","unstructured":"Callis J. The ubiquitination machinery of the ubiquitin system. Arabidopsis Book. 2014;12:e0174.","journal-title":"Arabidopsis Book"},{"key":"7037_CR66","doi-asserted-by":"publisher","DOI":"10.3390\/molecules26216682","author":"S Toma-Fukai","year":"2021","unstructured":"Toma-Fukai S, Shimizu T. Structural diversity of ubiquitin E3 ligase. Molecules. 2021. https:\/\/doi.org\/10.3390\/molecules26216682.","journal-title":"Molecules"},{"issue":"6","key":"7037_CR67","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/j.tig.2020.12.005","volume":"37","author":"F Mattiroli","year":"2021","unstructured":"Mattiroli F, Penengo L. Histone ubiquitination: an integrative signaling platform in genome stability. Trends Genet. 2021;37(6):566\u201381.","journal-title":"Trends Genet"},{"issue":"7578","key":"7037_CR68","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1038\/nature15401","volume":"527","author":"T Thorslund","year":"2015","unstructured":"Thorslund T, et al. Histone H1 couples initiation and amplification of ubiquitin signalling after DNA damage. Nature. 2015;527(7578):389\u201393.","journal-title":"Nature"},{"issue":"21","key":"7037_CR69","doi-asserted-by":"publisher","first-page":"e125","DOI":"10.1093\/nar\/gkac805","volume":"50","author":"W Qin","year":"2022","unstructured":"Qin W, et al. Probing protein ubiquitination in live cells. Nucleic Acids Res. 2022;50(21):e125.","journal-title":"Nucleic Acids Res"},{"issue":"6","key":"7037_CR70","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1016\/j.cell.2011.08.008","volume":"146","author":"M Tan","year":"2011","unstructured":"Tan M, et al. Identification of 67 histone marks and histone lysine crotonylation as a new type of histone modification. Cell. 2011;146(6):1016\u201328.","journal-title":"Cell"},{"issue":"7","key":"7037_CR71","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1038\/cr.2017.68","volume":"27","author":"W Wei","year":"2017","unstructured":"Wei W, et al. Class I histone deacetylases are major histone decrotonylases: evidence for critical and broad function of histone crotonylation in transcription. Cell Res. 2017;27(7):898\u2013915.","journal-title":"Cell Res"},{"issue":"2","key":"7037_CR72","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.molcel.2015.02.029","volume":"58","author":"BR Sabari","year":"2015","unstructured":"Sabari BR, et al. Intracellular crotonyl-CoA stimulates transcription through p300-catalyzed histone crotonylation. Mol Cell. 2015;58(2):203\u201315.","journal-title":"Mol Cell"},{"issue":"7","key":"7037_CR73","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1038\/cr.2017.60","volume":"27","author":"W Xu","year":"2017","unstructured":"Xu W, et al. Global profiling of crotonylation on non-histone proteins. Cell Res. 2017;27(7):946\u20139.","journal-title":"Cell Res"},{"issue":"3","key":"7037_CR74","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1038\/s41419-022-04725-9","volume":"13","author":"Y Zhang","year":"2022","unstructured":"Zhang Y, et al. Acox2 is a regulator of lysine crotonylation that mediates hepatic metabolic homeostasis in mice. Cell Death Dis. 2022;13(3):279.","journal-title":"Cell Death Dis"},{"issue":"4","key":"7037_CR75","doi-asserted-by":"publisher","first-page":"1743","DOI":"10.1021\/acs.jproteome.7b00012","volume":"16","author":"W Wei","year":"2017","unstructured":"Wei W, et al. Large-scale identification of protein crotonylation reveals its role in multiple cellular functions. J Proteome Res. 2017;16(4):1743\u201352.","journal-title":"J Proteome Res."},{"issue":"13","key":"7037_CR76","doi-asserted-by":"publisher","first-page":"3441","DOI":"10.7150\/ijbs.58872","volume":"17","author":"S Wang","year":"2021","unstructured":"Wang S, et al. The function and related diseases of protein crotonylation. Int J Biol Sci. 2021;17(13):3441\u201355.","journal-title":"Int J Biol Sci"},{"issue":"7","key":"7037_CR77","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1091\/mbc.6.7.793","volume":"6","author":"PB Meluh","year":"1995","unstructured":"Meluh PB, Koshland D. Evidence that the MIF2 gene of Saccharomyces cerevisiae encodes a centromere protein with homology to the mammalian centromere protein CENP-C. Mol Biol Cell. 1995;6(7):793\u2013807.","journal-title":"Mol Biol Cell"},{"issue":"11","key":"7037_CR78","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1038\/s41580-022-00500-y","volume":"23","author":"ACO Vertegaal","year":"2022","unstructured":"Vertegaal ACO. Signalling mechanisms and cellular functions of SUMO. Nat Rev Mol Cell Biol. 2022;23(11):715\u201331.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"9","key":"7037_CR79","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1038\/onc.2010.462","volume":"30","author":"Y Chu","year":"2011","unstructured":"Chu Y, Yang X. Sumo E3 ligase activity of TRIM proteins. Oncogene. 2011;30(9):1108\u201316.","journal-title":"Oncogene"},{"key":"7037_CR80","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1146\/annurev.biochem.78.101807.093809","volume":"78","author":"RJ Deshaies","year":"2009","unstructured":"Deshaies RJ, Joazeiro CA. Ring domain E3 ubiquitin ligases. Annu Rev Biochem. 2009;78:399\u2013434.","journal-title":"Annu Rev Biochem"},{"issue":"12","key":"7037_CR81","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1038\/nrm3478","volume":"13","author":"CM Hickey","year":"2012","unstructured":"Hickey CM, Wilson NR, Hochstrasser M. Function and regulation of SUMO proteases. Nat Rev Mol Cell Biol. 2012;13(12):755\u201366.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"7037_CR82","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1146\/annurev.biochem.73.011303.074118","volume":"73","author":"ES Johnson","year":"2004","unstructured":"Johnson ES. Protein modification by SUMO. Annu Rev Biochem. 2004;73:355\u201382.","journal-title":"Annu Rev Biochem"},{"issue":"15","key":"7037_CR83","doi-asserted-by":"publisher","first-page":"3110","DOI":"10.1111\/febs.15319","volume":"287","author":"AB Celen","year":"2020","unstructured":"Celen AB, Sahin U. Sumoylation on its 25th anniversary: mechanisms, pathology, and emerging concepts. FEBS J. 2020;287(15):3110\u201340.","journal-title":"FEBS J"},{"issue":"12","key":"7037_CR84","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1038\/nrn2276","volume":"8","author":"S Martin","year":"2007","unstructured":"Martin S, et al. Emerging extranuclear roles of protein SUMOylation in neuronal function and dysfunction. Nat Rev Neurosci. 2007;8(12):948\u201359.","journal-title":"Nat Rev Neurosci"},{"key":"7037_CR85","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.mad.2017.01.002","volume":"162","author":"A Princz","year":"2017","unstructured":"Princz A, Tavernarakis N. The role of SUMOylation in ageing and senescent decline. Mech Ageing Dev. 2017;162:85\u201390.","journal-title":"Mech Ageing Dev"},{"issue":"3","key":"7037_CR86","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1016\/0006-291X(92)91747-E","volume":"185","author":"S Kumar","year":"1992","unstructured":"Kumar S, Tomooka Y, Noda M. Identification of a set of genes with developmentally down-regulated expression in the mouse brain. Biochem Biophys Res Commun. 1992;185(3):1155\u201361.","journal-title":"Biochem Biophys Res Commun"},{"issue":"45","key":"7037_CR87","doi-asserted-by":"publisher","first-page":"28557","DOI":"10.1074\/jbc.272.45.28557","volume":"272","author":"T Kamitani","year":"1997","unstructured":"Kamitani T, et al. Characterization of NEDD8, a developmentally down-regulated ubiquitin-like protein. J Biol Chem. 1997;272(45):28557\u201362.","journal-title":"J Biol Chem"},{"issue":"1","key":"7037_CR88","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1038\/nrm3919","volume":"16","author":"RI Enchev","year":"2015","unstructured":"Enchev RI, Schulman BA, Peter M. Protein neddylation: beyond cullin-RING ligases. Nat Rev Mol Cell Biol. 2015;16(1):30\u201344.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"1","key":"7037_CR89","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1002\/bab.2112","volume":"69","author":"X He","year":"2022","unstructured":"He X, et al. Role of neddylation in neurological development and diseases. Biotechnol Appl Biochem. 2022;69(1):330\u201341.","journal-title":"Biotechnol Appl Biochem."},{"issue":"10","key":"7037_CR90","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1038\/embor.2008.183","volume":"9","author":"G Rabut","year":"2008","unstructured":"Rabut G, Peter M. Function and regulation of protein neddylation. Protein modifications: beyond the usual suspects\u2019 review series. EMBO Rep. 2008;9(10):969\u201376.","journal-title":"EMBO Rep"},{"issue":"Pt 5","key":"7037_CR91","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1042\/BST0360802","volume":"36","author":"DP Xirodimas","year":"2008","unstructured":"Xirodimas DP. Novel substrates and functions for the ubiquitin-like molecule NEDD8. Biochem Soc Trans. 2008;36(Pt 5):802\u20136.","journal-title":"Biochem Soc Trans"},{"key":"7037_CR92","doi-asserted-by":"publisher","first-page":"890121","DOI":"10.3389\/fcell.2022.890121","volume":"10","author":"J Zhu","year":"2022","unstructured":"Zhu J, et al. Association between neddylation and immune response. Front Cell Dev Biol. 2022;10:890121.","journal-title":"Front Cell Dev Biol"},{"issue":"14","key":"7037_CR93","doi-asserted-by":"publisher","first-page":"5017","DOI":"10.7150\/thno.78876","volume":"13","author":"ZX He","year":"2023","unstructured":"He ZX, et al. Targeting cullin neddylation for cancer and fibrotic diseases. Theranostics. 2023;13(14):5017\u201356.","journal-title":"Theranostics"},{"key":"7037_CR94","doi-asserted-by":"publisher","first-page":"586881","DOI":"10.3389\/fmed.2020.586881","volume":"7","author":"J Yao","year":"2020","unstructured":"Yao J, et al. Neddylation: a versatile pathway takes on chronic liver diseases. Front Med. 2020;7:586881.","journal-title":"Front Med."},{"issue":"4712","key":"7037_CR95","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1038\/185536a0","volume":"185","author":"EA Roberts","year":"1960","unstructured":"Roberts EA. Effect of glycosylation of the enzymic oxidation and translocation of flavonoids. Nature. 1960;185(4712):536\u20137.","journal-title":"Nature"},{"issue":"3","key":"7037_CR96","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1042\/bj1950639","volume":"195","author":"E Bause","year":"1981","unstructured":"Bause E, Legler G. The role of the hydroxy amino acid in the triplet sequence Asn-Xaa-Thr(Ser) for the N-glycosylation step during glycoprotein biosynthesis. Biochem J. 1981;195(3):639\u201344.","journal-title":"Biochem J"},{"issue":"7","key":"7037_CR97","doi-asserted-by":"publisher","first-page":"R229","DOI":"10.1016\/j.cub.2019.01.003","volume":"29","author":"J Eichler","year":"2019","unstructured":"Eichler J. Protein glycosylation. Curr Biol. 2019;29(7):R229-r231.","journal-title":"Curr Biol"},{"key":"7037_CR98","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.carres.2015.02.007","volume":"408","author":"HM Christensen","year":"2015","unstructured":"Christensen HM, Oscarson S, Jensen HH. Common side reactions of the glycosyl donor in chemical glycosylation. Carbohydr Res. 2015;408:51\u201395.","journal-title":"Carbohydr Res"},{"issue":"10","key":"7037_CR99","doi-asserted-by":"publisher","first-page":"3890","DOI":"10.1021\/acs.jproteome.0c00435","volume":"19","author":"H Wilkinson","year":"2020","unstructured":"Wilkinson H, Saldova R. Current methods for the characterization of O-glycans. J Proteome Res. 2020;19(10):3890\u2013905.","journal-title":"J Proteome Res"},{"issue":"12","key":"7037_CR100","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1038\/s41580-020-00294-x","volume":"21","author":"KT Schjoldager","year":"2020","unstructured":"Schjoldager KT, et al. Global view of human protein glycosylation pathways and functions. Nat Rev Mol Cell Biol. 2020;21(12):729\u201349.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"1","key":"7037_CR101","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.jcmgh.2022.09.013","volume":"15","author":"M Schonfeld","year":"2023","unstructured":"Schonfeld M, et al. Arginine methylation of integrin alpha-4 prevents fibrosis development in alcohol-associated liver disease. Cell Mol Gastroenterol Hepatol. 2023;15(1):39\u201359.","journal-title":"Cell Mol Gastroenterol Hepatol"},{"issue":"1","key":"7037_CR102","doi-asserted-by":"publisher","first-page":"4395","DOI":"10.1038\/s41598-018-22662-6","volume":"8","author":"D Ding","year":"2018","unstructured":"Ding D, et al. Trichostatin A inhibits the activation of hepatic stellate cells by increasing C\/EBP-\u03b1 acetylation in vivo and in vitro. Sci Rep. 2018;8(1):4395.","journal-title":"Sci Rep"},{"issue":"3","key":"7037_CR103","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1002\/hep.31418","volume":"73","author":"J Zhang","year":"2021","unstructured":"Zhang J, et al. Sirt6 alleviated liver fibrosis by deacetylating conserved lysine 54 on Smad2 in hepatic stellate cells. Hepatology. 2021;73(3):1140\u201357.","journal-title":"Hepatology"},{"issue":"1\u20132","key":"7037_CR104","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.jep.2005.09.040","volume":"105","author":"Y Tan","year":"2006","unstructured":"Tan Y, et al. Traditional Chinese medicine Bao Gan Ning increase phosphorylation of CREB in liver fibrosis in vivo and in vitro. J Ethnopharmacol. 2006;105(1\u20132):69\u201375.","journal-title":"J Ethnopharmacol"},{"issue":"7","key":"7037_CR105","doi-asserted-by":"publisher","first-page":"2346","DOI":"10.1002\/jcb.24107","volume":"113","author":"N Seki","year":"2012","unstructured":"Seki N, et al. Tricin inhibits proliferation of human hepatic stellate cells in vitro by blocking tyrosine phosphorylation of PDGF receptor and its signaling pathways. J Cell Biochem. 2012;113(7):2346\u201355.","journal-title":"J Cell Biochem"},{"issue":"8","key":"7037_CR106","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1016\/j.cmet.2023.06.013","volume":"35","author":"H Rho","year":"2023","unstructured":"Rho H, et al. Hexokinase 2-mediated gene expression via histone lactylation is required for hepatic stellate cell activation and liver fibrosis. Cell Metab. 2023;35(8):1406-1423.e8.","journal-title":"Cell Metab"},{"key":"7037_CR107","doi-asserted-by":"publisher","first-page":"644901","DOI":"10.3389\/fcell.2021.644901","volume":"9","author":"Y Zhu","year":"2021","unstructured":"Zhu Y, et al. TRIM26 induces ferroptosis to inhibit hepatic stellate cell activation and mitigate liver fibrosis through mediating SLC7A11 ubiquitination. Front Cell Dev Biol. 2021;9:644901.","journal-title":"Front Cell Dev Biol"},{"issue":"8\u20139","key":"7037_CR108","doi-asserted-by":"publisher","first-page":"3711","DOI":"10.1002\/jcb.29528","volume":"121","author":"H He","year":"2020","unstructured":"He H, et al. FBXO31 modulates activation of hepatic stellate cells and liver fibrogenesis by promoting ubiquitination of Smad7. J Cell Biochem. 2020;121(8\u20139):3711\u20139.","journal-title":"J Cell Biochem"},{"issue":"1","key":"7037_CR109","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1038\/s41467-019-14138-6","volume":"11","author":"J Zhou","year":"2020","unstructured":"Zhou J, et al. Sumoylation inhibitors synergize with FXR agonists in combating liver fibrosis. Nat Commun. 2020;11(1):240.","journal-title":"Nat Commun"},{"issue":"1","key":"7037_CR110","doi-asserted-by":"publisher","first-page":"7782","DOI":"10.1038\/s41467-022-35525-6","volume":"13","author":"C Xu","year":"2022","unstructured":"Xu C, et al. Hepatic neddylation deficiency triggers fatal liver injury via inducing NF-\u03baB-inducing kinase in mice. Nat Commun. 2022;13(1):7782.","journal-title":"Nat Commun"},{"key":"7037_CR111","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24043415","author":"R Li","year":"2023","unstructured":"Li R, et al. Neddylation of EphB1 regulates its activity and associates with liver fibrosis. Int J Mol Sci. 2023. https:\/\/doi.org\/10.3390\/ijms24043415.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"7037_CR112","doi-asserted-by":"publisher","first-page":"11006","DOI":"10.1038\/s41598-017-11212-1","volume":"7","author":"MH Wu","year":"2017","unstructured":"Wu MH, et al. Glycosylation-dependent galectin-1\/neuropilin-1 interactions promote liver fibrosis through activation of TGF-\u03b2- and PDGF-like signals in hepatic stellate cells. Sci Rep. 2017;7(1):11006.","journal-title":"Sci Rep"},{"issue":"4","key":"7037_CR113","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1016\/j.gendis.2022.08.013","volume":"10","author":"H Li","year":"2023","unstructured":"Li H, et al. Interplays of liver fibrosis-associated microRNAs: molecular mechanisms and implications in diagnosis and therapy. Genes Dis. 2023;10(4):1457\u201369.","journal-title":"Genes Dis"},{"issue":"11","key":"7037_CR114","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.1136\/gutjnl-2011-300717","volume":"61","author":"T Ogawa","year":"2012","unstructured":"Ogawa T, et al. Microrna-221\/222 upregulation indicates the activation of stellate cells and the progression of liver fibrosis. Gut. 2012;61(11):1600\u20139.","journal-title":"Gut"},{"issue":"52","key":"7037_CR115","doi-asserted-by":"publisher","first-page":"37082","DOI":"10.1074\/jbc.M113.517953","volume":"288","author":"Z Zhang","year":"2013","unstructured":"Zhang Z, et al. The autoregulatory feedback loop of microRNA-21\/programmed cell death protein 4\/activation protein-1 (miR-21\/PDCD4\/AP-1) as a driving force for hepatic fibrosis development. J Biol Chem. 2013;288(52):37082\u201393.","journal-title":"J Biol Chem"},{"issue":"1","key":"7037_CR116","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1002\/hep.23922","volume":"53","author":"C Roderburg","year":"2011","unstructured":"Roderburg C, et al. Micro-RNA profiling reveals a role for miR-29 in human and murine liver fibrosis. Hepatology. 2011;53(1):209\u201318.","journal-title":"Hepatology"},{"issue":"6","key":"7037_CR117","doi-asserted-by":"publisher","first-page":"4959","DOI":"10.1074\/jbc.M410078200","volume":"280","author":"H She","year":"2005","unstructured":"She H, et al. Adipogenic transcriptional regulation of hepatic stellate cells. J Biol Chem. 2005;280(6):4959\u201367.","journal-title":"J Biol Chem"},{"issue":"5","key":"7037_CR118","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1053\/j.gastro.2012.07.115","volume":"143","author":"Y Chen","year":"2012","unstructured":"Chen Y, et al. Hedgehog controls hepatic stellate cell fate by regulating metabolism. Gastroenterology. 2012;143(5):1319-1329.e11.","journal-title":"Gastroenterology"},{"key":"7037_CR119","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24065843","author":"X Wang","year":"2023","unstructured":"Wang X, et al. Resmetirom ameliorates NASH-model mice by suppressing STAT3 and NF-\u03baB signaling pathways in an RGS5-dependent manner. Int J Mol Sci. 2023. https:\/\/doi.org\/10.3390\/ijms24065843.","journal-title":"Int J Mol Sci"},{"issue":"7710","key":"7037_CR120","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1038\/s41586-018-0201-4","volume":"558","author":"M Hunkeler","year":"2018","unstructured":"Hunkeler M, et al. Structural basis for regulation of human acetyl-CoA carboxylase. Nature. 2018;558(7710):470\u20134.","journal-title":"Nature"},{"issue":"7710","key":"7037_CR121","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1038\/s41586-018-0201-4","volume":"558","author":"M Hunkeler","year":"2018","unstructured":"Hunkeler M, et al. Structural basis for regulation of human acetyl-CoA carboxylase. Nature. 2018;558(7710):470\u20134.","journal-title":"Nature"},{"issue":"2","key":"7037_CR122","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1080\/13543784.2020.1668374","volume":"29","author":"N Alkhouri","year":"2020","unstructured":"Alkhouri N, et al. GS-0976 (Firsocostat): an investigational liver-directed acetyl-CoA carboxylase (ACC) inhibitor for the treatment of non-alcoholic steatohepatitis (NASH). Expert Opinion Investig Drugs. 2020;29(2):135\u201341.","journal-title":"Expert Opinion Investig. Drugs"},{"issue":"4","key":"7037_CR123","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/j.jhep.2020.04.037","volume":"73","author":"J Bates","year":"2020","unstructured":"Bates J, et al. Acetyl-CoA carboxylase inhibition disrupts metabolic reprogramming during hepatic stellate cell activation. J Hepatol. 2020;73(4):896\u2013905.","journal-title":"J Hepatol"},{"key":"7037_CR124","doi-asserted-by":"publisher","first-page":"16044","DOI":"10.1038\/celldisc.2016.44","volume":"2","author":"J Wei","year":"2016","unstructured":"Wei J, et al. A unified molecular mechanism for the regulation of acetyl-CoA carboxylase by phosphorylation. Cell Discov. 2016;2:16044.","journal-title":"Cell Discov"},{"issue":"9","key":"7037_CR125","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1113\/EP085049","volume":"100","author":"T Ono","year":"2015","unstructured":"Ono T, et al. Curcumin ameliorates skeletal muscle atrophy in type 1 diabetic mice by inhibiting protein ubiquitination. Exp Physiol. 2015;100(9):1052\u201363.","journal-title":"Exp Physiol."},{"issue":"11","key":"7037_CR126","doi-asserted-by":"publisher","first-page":"2702","DOI":"10.3390\/nu11112702","volume":"11","author":"DE Lee","year":"2019","unstructured":"Lee DE, et al. Curcumin ameliorates nonalcoholic fatty liver disease through inhibition of O-GlcNAcylation. Nutrients. 2019;11(11):2702.","journal-title":"Nutrients"},{"key":"7037_CR127","doi-asserted-by":"publisher","first-page":"5667","DOI":"10.2147\/DDDT.S287442","volume":"14","author":"T Zhang","year":"2020","unstructured":"Zhang T, et al. Curcumin- and cyclopamine-loaded liposomes to enhance therapeutic efficacy against hepatic fibrosis. Drug Des Dev Ther. 2020;14:5667\u201378.","journal-title":"Drug Des Dev Ther"},{"key":"7037_CR128","doi-asserted-by":"publisher","first-page":"113197","DOI":"10.1016\/j.biopha.2022.113197","volume":"152","author":"WI Ho","year":"2022","unstructured":"Ho WI, et al. Liposome-encapsulated curcumin attenuates HMGB1-mediated hepatic inflammation and fibrosis in a murine model of Wilson\u2019s disease. Biomed Pharmacother. 2022;152:113197.","journal-title":"Biomed Pharmacother."},{"issue":"3","key":"7037_CR129","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1038\/s41430-018-0382-9","volume":"73","author":"S Saadati","year":"2019","unstructured":"Saadati S, et al. The effects of curcumin supplementation on liver enzymes, lipid profile, glucose homeostasis, and hepatic steatosis and fibrosis in patients with non-alcoholic fatty liver disease. Eur J Clin Nutr. 2019;73(3):441\u20139.","journal-title":"Eur J Clin Nutr."},{"issue":"3","key":"7037_CR130","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1007\/s00109-020-01878-y","volume":"98","author":"JM Ogier","year":"2020","unstructured":"Ogier JM, Nayagam BA, Lockhart PJ. ASK1 inhibition: a therapeutic strategy with multi-system benefits. J Mol Med. 2020;98(3):335\u201348.","journal-title":"J Mol Med."},{"issue":"6","key":"7037_CR131","doi-asserted-by":"publisher","first-page":"527","DOI":"10.4062\/biomolther.2020.016","volume":"28","author":"YC Yoon","year":"2020","unstructured":"Yoon YC, et al. Selonsertib inhibits liver fibrosis via downregulation of ASK1\/ MAPK pathway of hepatic stellate cells. Biomol Ther. 2020;28(6):527\u201336.","journal-title":"Biomol Ther."},{"issue":"1","key":"7037_CR132","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.jhep.2020.02.027","volume":"73","author":"SA Harrison","year":"2020","unstructured":"Harrison SA, et al. Selonsertib for patients with bridging fibrosis or compensated cirrhosis due to NASH: results from randomized phase III STELLAR\u00a0trials. J Hepatol. 2020;73(1):26\u201339.","journal-title":"J Hepatol."},{"issue":"6","key":"7037_CR133","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1080\/09537104.2020.1802415","volume":"32","author":"C Dangelmaier","year":"2021","unstructured":"Dangelmaier C, Kunapuli SP. Protease-activated receptor 4 causes Akt phosphorylation independently of PI3 kinase pathways. Platelets. 2021;32(6):832\u20137.","journal-title":"Platelets"},{"issue":"6","key":"7037_CR134","doi-asserted-by":"publisher","first-page":"1911","DOI":"10.1021\/acs.jafc.1c07578","volume":"70","author":"Z He","year":"2022","unstructured":"He Z, et al. Ginsenoside Rg2 ameliorating CDAHFD-induced hepatic fibrosis by regulating AKT\/mTOR-mediated autophagy. J Agric Food Chem. 2022;70(6):1911\u201322.","journal-title":"J Agric Food Chem."},{"issue":"2","key":"7037_CR135","first-page":"429","volume":"25","author":"\u00c1 Pet\u0151","year":"2020","unstructured":"Pet\u0151 \u00c1, et al. Pharmacological overview of the BGP-15 chemical agent as a new drug candidate for the treatment of symptoms of metabolic syndrome. Mol Basel Switz. 2020;25(2):429.","journal-title":"Mol Basel Switz."},{"issue":"1","key":"7037_CR136","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1038\/s41392-023-01439-y","volume":"8","author":"X Wu","year":"2023","unstructured":"Wu X, et al. Targeting protein modifications in metabolic diseases: molecular mechanisms and targeted therapies. Signal Transduct Target Ther. 2023;8(1):220.","journal-title":"Signal Transduct Target Ther."},{"issue":"5","key":"7037_CR137","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1016\/j.jhep.2023.07.034","volume":"79","author":"L Adorini","year":"2023","unstructured":"Adorini L, Trauner M. FXR agonists in NASH treatment. J Hepatol. 2023;79(5):1317\u201331.","journal-title":"J Hepatol."},{"issue":"1","key":"7037_CR138","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1038\/s41467-019-14138-6","volume":"11","author":"J Zhou","year":"2020","unstructured":"Zhou J, et al. SUMOylation inhibitors synergize with FXR agonists in combating liver fibrosis. Nat Commun. 2020;11(1):240.","journal-title":"Nat Commun."},{"issue":"2","key":"7037_CR139","doi-asserted-by":"publisher","first-page":"184","DOI":"10.15252\/embj.201489527","volume":"34","author":"DH Kim","year":"2015","unstructured":"Kim DH, et al. A dysregulated acetyl\/SUMO switch of FXR promotes hepatic inflammation in obesity. EMBO J. 2015;34(2):184\u201399.","journal-title":"EMBO J."},{"issue":"5","key":"7037_CR140","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/j.cmet.2009.09.009","volume":"10","author":"JK Kemper","year":"2009","unstructured":"Kemper JK, et al. FXR acetylation is normally dynamically regulated by p300 and SIRT1 but constitutively elevated in metabolic disease states. Cell Metab. 2009;10(5):392\u2013404.","journal-title":"Cell Metab."},{"issue":"1","key":"7037_CR141","doi-asserted-by":"publisher","first-page":"60","DOI":"10.3390\/biomedicines9010060","volume":"9","author":"P Schwabl","year":"2021","unstructured":"Schwabl P, et al. The non-steroidal FXR agonist cilofexor improves portal hypertension and reduces hepatic fibrosis in a rat NASH model. Biomedicines. 2021;9(1):60.","journal-title":"Biomedicines"},{"issue":"2","key":"7037_CR142","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1002\/hep.31622","volume":"73","author":"R Loomba","year":"2021","unstructured":"Loomba R, et al. Combination therapies including cilofexor and firsocostat for bridging fibrosis and cirrhosis attributable to NASH. Hepatology. 2021;73(2):625\u201343.","journal-title":"Hepatology"},{"issue":"14","key":"7037_CR143","doi-asserted-by":"publisher","first-page":"6722","DOI":"10.1016\/S0021-9258(18)68702-2","volume":"263","author":"NK Tonks","year":"1988","unstructured":"Tonks NK, Diltz CD, Fischer EH. Purification of the major protein-tyrosine-phosphatases of human placenta. J Biol Chem. 1988;263(14):6722\u201330.","journal-title":"J Biol Chem"},{"issue":"4","key":"7037_CR144","doi-asserted-by":"publisher","first-page":"246","DOI":"10.2174\/1568026619666190201152153","volume":"19","author":"P Eleftheriou","year":"2019","unstructured":"Eleftheriou P, Geronikaki A, Petrou A. PTP1b Inhibition, a promising approach for the treatment of diabetes type II. Curr Top Med Chem. 2019;19(4):246\u201363.","journal-title":"Curr Top Med Chem."},{"key":"7037_CR145","first-page":"3803056","volume":"2023","author":"L Bourebaba","year":"2023","unstructured":"Bourebaba L, et al. The PTP1B inhibitor trodusquemine (MSI-1436) improves glucose uptake in equine metabolic syndrome affected liver through anti-inflammatory and antifibrotic activity. Int J Inflamm. 2023;2023:3803056.","journal-title":"Int J Inflamm."},{"issue":"5","key":"7037_CR146","doi-asserted-by":"publisher","first-page":"305","DOI":"10.3892\/mmr.2021.11944","volume":"23","author":"HM Huang","year":"2021","unstructured":"Huang HM, et al. Histone deacetylase inhibitor givinostat alleviates liver fibrosis by regulating hepatic stellate cell activation. Mol Med Rep. 2021;23(5):305.","journal-title":"Mol Med Rep."},{"issue":"2","key":"7037_CR147","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1080\/13543784.2020.1668374","volume":"29","author":"N Alkhouri","year":"2020","unstructured":"Alkhouri N, et al. GS-0976 (firsocostat): an investigational liver-directed acetyl-CoA carboxylase (ACC) inhibitor for the treatment of non-alcoholic steatohepatitis (NASH). Expert Opin Investig Drugs. 2020;29(2):135\u201341.","journal-title":"Expert Opin Investig Drugs"},{"issue":"6","key":"7037_CR148","doi-asserted-by":"publisher","first-page":"527","DOI":"10.4062\/biomolther.2020.016","volume":"28","author":"YC Yoon","year":"2020","unstructured":"Yoon YC, et al. Selonsertib inhibits liver fibrosis via downregulation of ASK1\/ MAPK pathway of hepatic stellate cells. Biomol Ther (Seoul). 2020;28(6):527\u201336.","journal-title":"Biomol Ther (Seoul)"},{"issue":"1","key":"7037_CR149","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.jhep.2020.02.027","volume":"73","author":"SA Harrison","year":"2020","unstructured":"Harrison SA, et al. Selonsertib for patients with bridging fibrosis or compensated cirrhosis due to NASH: results from randomized phase III stellar trials. J Hepatol. 2020;73(1):26\u201339.","journal-title":"J Hepatol"},{"issue":"8","key":"7037_CR150","doi-asserted-by":"publisher","DOI":"10.14309\/ctg.0000000000000744","volume":"15","author":"C Levy","year":"2024","unstructured":"Levy C, et al. Cilofexor in patients with compensated cirrhosis due to primary sclerosing cholangitis: an open-label phase 1B study. Clin Transl Gastroenterol. 2024;15(8):e00744.","journal-title":"Clin Transl Gastroenterol"},{"issue":"4","key":"7037_CR151","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1111\/liv.15816","volume":"44","author":"N Alkhouri","year":"2024","unstructured":"Alkhouri N, et al. Safety, pharmacokinetics and pharmacodynamics of obeticholic acid in subjects with fibrosis or cirrhosis from NASH. Liver Int. 2024;44(4):966\u201378.","journal-title":"Liver Int"},{"issue":"1","key":"7037_CR152","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1038\/s41401-024-01351-3","volume":"46","author":"BX Tang","year":"2025","unstructured":"Tang BX, et al. Luteolin-7-diglucuronide, a novel PTP1B inhibitor, ameliorates hepatic stellate cell activation and liver fibrosis in mice. Acta Pharmacol Sin. 2025;46(1):122\u201333.","journal-title":"Acta Pharmacol Sin"},{"issue":"5","key":"7037_CR153","doi-asserted-by":"publisher","DOI":"10.3892\/mmr.2021.11944","volume":"23","author":"HM Huang","year":"2021","unstructured":"Huang HM, et al. Histone deacetylase inhibitor givinostat alleviates liver fibrosis by regulating hepatic stellate cell activation. Mol Med Rep. 2021;23(5):305.","journal-title":"Mol Med Rep"},{"issue":"2","key":"7037_CR154","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.gpb.2013.01.009","volume":"11","author":"JA Paulo","year":"2013","unstructured":"Paulo JA, et al. Mass spectrometry-based quantitative proteomic profiling of human pancreatic and hepatic stellate cell lines. Genomics Proteomics Bioinf. 2013;11(2):105\u201313.","journal-title":"Genomics Proteomics Bioinf"},{"issue":"5","key":"7037_CR155","doi-asserted-by":"publisher","first-page":"e378","DOI":"10.1002\/mco2.378","volume":"4","author":"S Cheng","year":"2023","unstructured":"Cheng S, et al. Single-cell RNA sequencing reveals the heterogeneity and intercellular communication of hepatic stellate cells and macrophages during liver fibrosis. J MedComm. 2023;4(5):e378.","journal-title":"J. MedComm."},{"issue":"1","key":"7037_CR156","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1186\/s13046-024-03169-7","volume":"43","author":"H Zhu","year":"2024","unstructured":"Zhu H, et al. CCT3\/ACTN4\/TFRC axis protects hepatocellular carcinoma cells from ferroptosis by inhibiting iron endocytosis. J Exp Clin Cancer Res. 2024;43(1):245.","journal-title":"J Exp Clin Cancer Res"},{"issue":"3","key":"7037_CR157","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.mcna.2022.12.001","volume":"107","author":"D Chee","year":"2023","unstructured":"Chee D, et al. The past, present, and future of noninvasive test in chronic liver diseases. Med Clin North Am. 2023;107(3):397\u2013421.","journal-title":"Med Clin North Am"},{"key":"7037_CR158","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics13040788","author":"MG Taru","year":"2023","unstructured":"Taru MG, et al. How to identify advanced fibrosis in adult patients with non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) using ultrasound elastography-a review of the literature and proposed multistep approach. Diagnostics. 2023. https:\/\/doi.org\/10.3390\/diagnostics13040788.","journal-title":"Diagnostics"},{"issue":"9","key":"7037_CR159","doi-asserted-by":"publisher","first-page":"2042","DOI":"10.1111\/liv.15130","volume":"42","author":"T Torimura","year":"2022","unstructured":"Torimura T, Iwamoto H. Treatment and the prognosis of hepatocellular carcinoma in Asia. Liver Int. 2022;42(9):2042\u201354.","journal-title":"Liver Int"},{"key":"7037_CR160","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.jare.2021.01.018","volume":"33","author":"B Tang","year":"2021","unstructured":"Tang B, et al. Diagnosis and prognosis models for hepatocellular carcinoma patient\u2019s management based on tumor mutation burden. J Adv Res. 2021;33:153\u201365.","journal-title":"J Adv Res"},{"issue":"2","key":"7037_CR161","first-page":"100779","volume":"18","author":"K Vyas","year":"2023","unstructured":"Vyas K, Patel MM. Insights on drug and gene delivery systems in liver fibrosis. Asian J Pharm Sci. 2023;18(2):100779.","journal-title":"Asian J Pharm Sci"},{"key":"7037_CR162","doi-asserted-by":"publisher","first-page":"765","DOI":"10.2147\/IJN.S394802","volume":"18","author":"Y Lu","year":"2023","unstructured":"Lu Y, et al. An overview of drug delivery nanosystems for sepsis-related liver injury treatment. Int J Nanomedicine. 2023;18:765\u201379.","journal-title":"Int J Nanomedicine"},{"key":"7037_CR163","doi-asserted-by":"crossref","first-page":"72","DOI":"10.3389\/fmed.2015.00072","volume":"2","author":"F van Dijk","year":"2015","unstructured":"van Dijk F, et al. Targeted therapies in liver fibrosis: combining the best parts of platelet-derived growth factor BB and interferon gamma. Front Med. 2015;2:72.","journal-title":"Front Med"},{"key":"7037_CR164","doi-asserted-by":"publisher","first-page":"111572","DOI":"10.1016\/j.mad.2021.111572","volume":"199","author":"M Zhang","year":"2021","unstructured":"Zhang M, et al. Hepatic stellate cell senescence in liver fibrosis: characteristics, mechanisms and perspectives. Mech Ageing Dev. 2021;199:111572.","journal-title":"Mech Ageing Dev"},{"key":"7037_CR165","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.addr.2020.08.003","volume":"159","author":"S Busatto","year":"2020","unstructured":"Busatto S, et al. Lipoprotein-based drug delivery. Adv Drug Deliv Rev. 2020;159:377\u201390.","journal-title":"Adv Drug Deliv Rev"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-025-07037-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-025-07037-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-025-07037-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T11:09:22Z","timestamp":1759316962000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-025-07037-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,1]]},"references-count":165,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["7037"],"URL":"https:\/\/doi.org\/10.1186\/s12967-025-07037-6","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,1]]},"assertion":[{"value":"24 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"The authors declare no conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1036"}}